Page last updated: 2024-10-27

fluorouracil and Anti-Phospholipid Antibody Syndrome

fluorouracil has been researched along with Anti-Phospholipid Antibody Syndrome in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"Suspected pulmonary embolism was demonstrated by CT scan."1.31[Complicated antiphospholid antibody syndrome]. ( Eifrig, B; Hegewisch-Becker, S; Hossfeld, DK; Langer, F; Marx, G; Neuber, K, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Langer, F1
Eifrig, B1
Hegewisch-Becker, S1
Marx, G1
Neuber, K1
Hossfeld, DK1

Other Studies

1 other study available for fluorouracil and Anti-Phospholipid Antibody Syndrome

ArticleYear
[Complicated antiphospholid antibody syndrome].
    Deutsche medizinische Wochenschrift (1946), 2002, Jul-05, Volume: 127, Issue:27

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiphospholipid Syndrome; Breast Neoplasms; Carcino

2002